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Background/Aims
Irritable bowel syndrome (IBS) is a common disorder with significant morbidity and impairment of quality of life. Most patients 
(26%-83%) with IBS from Asia reported bloating. Bloating may result from increased amount or distribution of gas in the gut 
or exaggerated perception of distension. To evaluate whether patients with IBS produce more hydrogen even in fasting state, 
we conducted a study with the following aims: (1) to estimate fasting breath hydrogen levels among patients with IBS as 
compared with healthy controls (HC) and (2) to study relationship between symptoms of IBS and stool frequency and fasting 
breath hydrogen levels. 
Methods
Eighty-one patients with IBS (Rome III criteria) and 123 HC were included. Hydrogen breath test was performed using a gas 
analyzer after an overnight (12 hours) fast. Both patients with IBS and HC had similar preparation before breath hydrogen 
estimation. 
Results
Of 93 patients with symptoms of functional gastrointestinal disorders, 81 (87.1%) met Rome III criteria and 12 (12.9%) were 
negative and hence, excluded from the study. Patients with IBS were comparable in age (35 ± 11.8 years vs 37.5 ± 13.1 years, 
p = NS) and gender (male 61/81 [75.3%] vs 77/123 [62.6%], p=0.67) with HC. Average fasting breath hydrogen was higher 
in patients with IBS as compared to HC (mean 10.1 ± 6.5 ppm vs 5.5 ± 6.2 ppm, p < 0.0001). Number of stools per week 
correlated with average fasting breath hydrogen excretion in patients with IBS (r = 0.26, p = 0.02). 
Conclusions
Inspite of similar preparation for the test, fasting breath hydrogen was higher in patients with IBS as compared to HC. 
Number of stools per week correlated with fasting breath hydrogen levels among patients with IBS. 
(J Neurogastroenterol Motil 2010;16:299-305)
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Introduction
Irritable bowel syndrome (IBS) is a common gastrointestinal 
disorder with significant morbidity,
1 impairment of quality of 
life
2 and work absenteeism.
3 Most patients (26%-83%) with IBS 
from Asia reported bloating.
4 Bloating may result from increased 
amount of gas or its abnormal movement in the gut or increased 
perception of the distension.
5 A few studies using computerized 
tomography or radiographs of abdomen revealed higher amount 
of gas in patients with IBS.
6,7 A study using infusion of radio-
active xenon gas into small bowel revealed that patient with IBS 
tend to trap the gas in small bowel, which has low ability to dis-
tend compared to colon whereas, in healthy subjects the gas 
moved down to the colon.
8 In another study from our center, pa-
tients with IBS complained of more symptoms than healthy sub-
jects to a comparable level of hydrogen production following lac-
tose load, which was likely to be related to visceral hypersen-
sitivity.
9 In a recent study, it was found that patients with IBS 
were less often methane producers compared with the healthy 
subjects.
10 Since 4 atoms of hydrogen combine to produce 1 mol-
ecule of methane, the authors suggested that increased frequency 
of bloating among patients with IBS might be explained by re-
duced methane production among them.
10 However, there is no 
study directly comparing fasting breath hydrogen among patients 
with IBS and healthy subjects and relationship between various 
symptoms of IBS and fasting breath hydrogen levels.
Hwang et al
11 suggested that methane production among pa-
tients with IBS was associated with constipation. Methane slows 
the gut transit, therefore, may cause constipation.
11 Hence, it is 
logical to propose that excess hydrogen production should be as-
sociated with higher stool frequency. In a recent study from our 
center, patients with chronic non-specific diarrhea produced 
more hydrogen than those with IBS and healthy subjects in re-
sponse to glucose load.
12 Hence, it is interesting to evaluate 
whether there is any relationship between fasting breath hydro-
gen levels and stool frequency. Accordingly, we aimed to study: 
(1) fasting breath hydrogen levels among patients with IBS as 
compared to healthy subjects with same preparation and (2) rela-
tionship between symptoms of IBS and stool frequency and fast-
ing breath hydrogen levels.  
Materials and Methods
1. Study subjects 
From December 2008 to February 2010, 93 patients with 
functional lower gastrointestinal disorder referred to Gastrointes-
tinal Pathophysiology and Motility Laboratory of the Depart-
ment of Gastroenterology of a tertiary referral center in the north-
ern India for breath hydrogen testing and 123 healthy controls 
(HC) were included. IBS was diagnosed using Rome III 
criteria.
13 IBS was classified into diarrhea predominant (D-IBS) 
and constipation predominant (C-IBS) on subjective feeling of 
bowel movement. Also, on Bristol stool form scale, stool type 1, 2 
and 3 were taken as C-IBS and 5, 6 and 7 were taken as D-IBS; 
those who reported alternating type of stool were taken as I-IBS 
(indeterminate type-IBS) (Asian IBS consensus).
14 HC were se-
lected from the community or staff members of the institute ex-
cluding those fulfilling criteria for IBS on enquiry. The study 
protocol was approved by the Institutional Ethics committee. 
Informed consent was obtained from all the patients and HC. 
Patients who received antibiotics, proton pump inhibitors and 
promotility or antimotility drugs within 4 weeks before inclusion 
into the study were excluded.
2. Hydrogen breath test
Hydrogen breath test was performed using a breath gas ana-
lyzer (Bedfont gastrolyzer, Bedfont Scientific Ltd, ME13QX, 
England) after an overnight (12 hours) fast.
15
3. Patient preparation
Both the patients with IBS and HC were asked to avoid slowly 
absorbed carbohydrates (like bread and potato) and fiber during the 
previous 48 hours before the test as this might lead to high basal lev-
els of hydrogen in the breath.
16 Subjects were not allowed to take 
fruits, vegetables, and legumes. Also, they were asked not to ingest 
any beans, nuts, soy or large meals, and to limit dairy intake the day 
before the test. Patients who were on lactulose were asked to stop it 
72 hours before the test. Cigarette smoking and exercise were avoid-
ed 2 hours before and during the test, as hyperventilation can cause 
changes in breath hydrogen content. The subjects were then asked 
to brush their teeth and rinse their mouth with antiseptic mouth 
wash (chlorhexidine) and tap water before the test. Three values of 
breath hydrogen were recorded from each subject every 5-minute in 
fasting state and an average of these values was also taken.
16Elevated Fasting Breath Hydrogen Level in IBS
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Table 1. Demographic and Clinical and Laboratory Parameters of Patients With IBS and Healthy Controls
Parameters IBS (n = 81) HC (n = 123) p-value
Age (yr) 35.0 ± 11.8 37.5 ± 13.1       NS
Gender (male, n [%]) 61 (75.3)  77 (62.6)      0.67
Hemoglobin (g/dL)  13.5 ± 1.9          −        −
ESR (mm/hr)  18.2 ± 13.9          −        −
Symptoms
Abdominal pain  68 (84.0%)    5 (4.1%) < 0.0001
Abdominal discomfort  81 (100.0%)    5 (4.1%) < 0.0001
Abdominal distension/bloating 78 (96.3%)  13 (10.6%) < 0.0001
Passage of mucus  54 (66.7%)    0        −
Feeling of incomplete evacuation  54 (66.7%)  17 (13.8%) < 0.0001
Abdominal pain/discomfort relieved after defecation 73 (90.1%)    5 (4.1%) < 0.0001
Urgency to pass stool 26 (32.1%)    0        −
Loose stool at onset of pain 77 (95.1%)    3 (2.4%) < 0.0001
Straining during defecation 73 (90.1%)    0        −
Number of stool/week (mean ± SD) 25 (2-56)    7 (7-14) < 0.0001
Relief of pain with bowel movement 77 (95.1%)    5 (4.1%) < 0.0001
More frequent stools at onset of pain 68 (84.0%)    5 (4.1%) < 0.0001
IBS, irritable bowel syndrome; HC, healthy control; ESR, erythrocyte sedimentation rate. 
Values within parenthesis indicate percentage. Continuous data is presented as mean and SD. The categorical and continuous data were compared using chi-square test, 
and Student's t test, respectively.
4. Clinical evaluation 
Subjects were given a bowel symptom questionnaire. Symp-
toms included bloating, excess gas, diarrhea, constipation and ab-
dominal pain, passage of mucus, feeling of incomplete evacua-
tion, straining, and urgency. The patients were asked how they 
feel about their bowel movements (diarrhea or constipation). 
Western definitions of constipation (less than 3 stools per week)
17 
and diarrhea (more than 3 stools per day)
17 were also applied. 
Bristol Stool Form Scale was also used to define bowel pattern.
18 
5. Statistical methods
Categorical and continuous data were analyzed using chi- 
square and Mann-Whitney U test, respectively. The time by 
group interaction was analyzed using repeated measures ANOVA 
(General linear model). Spearman rank correlation was used to 
evaluate the relationship between each pair of continuous variables. 
The p-values less than 0.05 were considered significance.
Results
1. Demographic and clinical parameters
Of the 93 patients with functional lower gastrointestinal 
symptoms, 81 (87.1%) fulfilled Rome III criteria for IBS and 12 
(12.9%) were negative and hence, excluded from this study. 
Patients with IBS were comparable in age (mean 35 ± 11.8 years 
vs 37.5 ± 13.1 years, p = NS) and gender (male 61/81 [75.3%] 
vs 77/123 (62.6%), p = 0.67) with HC (Table 1). On subjective 
feeling of bowel movement, of 81 patients with IBS 50 (61.7%) 
and 29 (35.8%) were constipation and diarrhea predominant, re-
spectively while 2 (2.5%) patients felt neither constipation nor 
diarrhea. Of 81 patients with IBS, 3 (3.7%), 4 (4.9%), 18 
(22.2%), 13 (16%), 15 (18.5%) and 28 (34.6%) were passing 
Bristol stool type 1, type 2, type 3, type 4, type 5 and type 6, 
respectively. Of 128 HC initially screened, 5 were excluded from 
the study as they fulfilled Rome III criteria for IBS.
2. Fasting breath hydrogen in IBS and HC  
Average fasting breath hydrogen concentration was higher in 
patients with IBS as compared to HC (mean 10.1 ± 6.5 ppm vs 
5.5 ± 6.2 ppm, p < 0.0001; Fig. 1). There was significant dif-
ference in fasting breath hydrogen excretion at different time in 
patients with IBS as compared to HC (Type III sum of squares 
= 31.366, p = 0.041; Fig. 2). 12/123 (10%) HC and 20/81 
(25%) patients with IBS had fasting breath hydrogen value more 
than 16 ppm. There was no difference in excretion of fasting 
breath hydrogen among patients with D-IBS and C-IBS (either Sunil Kumar, et al
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Figure 1. Comparison of fasting breath hydrogen level in patients 
with irritable bowel syndrome and healthy controls. IBS, irritable 
bowel syndrome; HC, healthy controls.
Figure 2. Comparison of fasting breath hydrogen level in patients 
with irritable bowel syndrome and healthy controls at different time 
interval using repeated measures of ANOVA. IBS, irritable bowel 
syndrome; HC, healthy controls.
by subjective feeling or by Bristol stool form).  
3. Correlation between stool frequency and fasting 
breath hydrogen excretion 
There was a positive correlation between number of stools 
per week and average fasting breath hydrogen excretion in pa-
tients with IBS (r = 0.26, p = 0.02). There was positive correla-
tion between frequency of stools per week and average fasting 
breath hydrogen excretion in patients with IBS who reported 
subjective feeling of diarrhea (r = 0.45, p = 0.01) and D-IBS 
(according to Bristol Stool Form Scale, r = 0.35; p = 0.02). In 
contrast, there was no correlation between frequency of stools per 
week and average fasting breath hydrogen excretion in patients 
with IBS who reported subjective feeling of constipation and 
C-IBS (according to Bristol stool type).
Discussion
The present study showed that inspite of similar preparation 
for the test, fasting breath hydrogen excretion was higher in pa-
tients with IBS as compared to HC. Also, number of stools per 
week correlated with fasting breath hydrogen levels among pa-
tients with IBS. But, there was no difference in fasting breath hy-
drogen excretion in patients with D-IBS and C-IBS.
Chami et al
19 reported that comparison between the quantity 
of bowel gas of patients with IBS and HC using plain abdominal 
radiographs resulted in a marked difference in measured values. 
However, our study is perhaps the first study documenting in-
creased breath hydrogen in patients with IBS compared to HC. 
In a recent study, methane production was found commoner 
among HC (34.6%) than patients with IBS (14.5%).
10 Since 4 
atoms of hydrogen combine to produce 1 molecule of methane, 
the authors suggested that increased frequency of bloating among 
patients with IBS might be explained by reduced methane pro-
duction among them.
10 In another study, Peled et al
20 also re-
ported methane production to be commoner among controls 
(50.0%) than patients with IBS (34.4%). Since methane pro-
duction is expected to have an inverse relationship with hydrogen 
levels, these studies support our finding of increased breath hy-
drogen among patients with IBS than HC. Since as high as 96% 
of our patients had abdominal bloating, increased hydrogen gas 
production, at least partly might explain abdominal bloating in 
IBS. 
Fasting breath hydrogen levels were comparable among pa-
tients with IBS and controls in a study by Bratten et al
21 from 
United States of America (5 vs 7 ppm, respectively). However, 
the 2 groups were not comparable as control population was 
10-year younger than the IBS population.
21 Furthermore, in that 
study, baseline hydrogen level was significantly lower among 
methane producing IBS than those without methane 
production.
21 Interestingly, in this study, patients with IBS 
(20%)
21 were more often methane producer than control pop-
ulation (15%),
21 though not significant statistically; this in con-
trast to a large study that found methane production to be less 
common among IBS than controls.
10 Hence, contradictory result 
in the study by Bratten et al
21 as compared with the present study 
might be related to non-comparable IBS and control group and Elevated Fasting Breath Hydrogen Level in IBS
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bias in selection of IBS patients.  
In another study by Riordan et al
22 from Australia, median 
fasting breath hydrogen among 45 controls was 5 ppm (range, 
1-19). This is in accordance with the results in our control 
population. In that study, the upper 95% confidence limit (mean 
+ 2 standard deviation) of square root of fasting breath hydrogen 
value was 4 ppm, corresponding to a measured value of fasting 
breath hydrogen of 16 ppm. Hence, the authors considered > 16 
ppm as abnormal and considered it to be diagnostic of small in-
testinal bacterial overgrowth (SIBO) with a sensitivity and specif-
icity of 22% and 75%, respectively considering the result of quan-
titative bacterial culture of distal duodenal aspirate as the gold 
standard. 10% HC and 25% patients with IBS had fasting breath 
hydrogen value more than 16 ppm in our study. This is in dis-
cordance with our previous studies that showed 8.5% to 13% IBS 
had SIBO compared with 2% HC using glucose hydrogen 
breath test
9,12,23; these data, therefore, further substantiate that 
fasting breath hydrogen alone should not be used as a criterion 
for diagnosis of SIBO as reported by some authors pre-
viously.
24,25 Poor performance of fasting breath hydrogen in diag-
nosis of SIBO has been shown by Riordan et al
22 too. 
Chatterjee et al
26 showed that methane production correlated 
with constipation in patients with IBS. This is related to slowing 
of gut transit by methane.
26 Our finding of correlation of stool 
frequency per week and fasting breath hydrogen level, albeit 
weakly, suggests fasting breath hydrogen levels might correlate 
with diarrhea. In another study, we found that patients with 
chronic non-specific diarrhea produced more breath hydrogen 
than those with IBS and HC.
12 Lack of significant difference in 
fasting breath hydrogen among patients with D-IBS and C-IBS 
might be related to criteria used to subtype, as it was based on 
Bristol stool type or subjective feeling rather than stool frequency. 
Also, patients with IBS with incomplete evacuation might visit 
toilet repeatedly resulting in spuriously increased stool frequency. 
Other explanation of abdominal bloating in patients with IBS 
may be related to abnormal movement of gas within gut
27 and vis-
ceral hypersensitivity.
5,28 Indeed, earlier studies have shown that 
patients with IBS had abnormal handling and tolerance of in-
testinal gas; when challenged with an exogenous gas load, these 
patients developed gas retention and symptoms.
29,30 Further, 
studies have shown that this abnormality might be related to im-
paired transit of gas in the small bowel, rather than in the 
colon.
31,32 Healthy subjects were able to propel gas from the gut 
when it was infused into the proximal jejunum at a rate as high as 
30 mL/min.
33 Patients complaining of bloating retain gas infused 
into the proximal jejunum, but the clearance of gas infused into 
the distal ileum and the cecum was normal.
32 Furthermore, scin-
tigraphic studies measuring transit of labeled gas showed that im-
paired clearance of gas from the gut was due to delayed gas transit 
in the small bowel.
8,31 Also, we have shown that patients with IBS 
more often reported symptoms (bloating, distention, and diar-
rhea) following 50 g lactose load than HC inspite of a similar fre-
quency of lactose malabsorption in the 2 groups and comparable 
amount of hydrogen production.
9 In a previous study, patients 
with IBS more often reported symptoms following ingestion of 
dairy products (60% vs 27%) inspite of the same frequency of lac-
tose malabsorption as HC.
34 This might be related to visceral hy-
persensitivity or a decreased pain threshold in patients with IBS, 
which is common.
35, 36 
What could be the reason for higher hydrogen production in 
patients with IBS? Since the preparation before the test was sim-
ilar among the 2 groups, it is unlikely to be related to difference in 
the dietary intake. Gut flora in patients with IBS may differ from 
that in HC.
37 In a study on 20 patients with IBS, Balsari et al
37 
showed that there was considerable homogeneity in the fecal 
flora, and that there was a decrease of Coliforms, Lactobacilli and 
Bifidobacteria in patients with IBS compared with HC. Lactoba-
cilli are less gas producing than some other bacteria, such as 
Clostridia and Enterobacteriaceae.
38 Administration and coloniza-
tion of the gut with Lactobacilli of patients with IBS have been as-
sociated with reduced gas related symptoms.
39 Thus, the abnor-
mal gut flora in patients with IBS might cause higher excretion of 
fasting breath hydrogen. Small intestinal bacterial overgrowth is 
commoner among patients with IBS than HC.
40 Since SIBO can 
be associated with higher amount of hydrogen production in fast-
ing state,
41-43 this can be another explanation for our observation. 
In conclusion, the present study showed that inspite of sim-
ilar preparation for the test, fasting breath hydrogen excretion 
was higher in patients with IBS as compared to HC. Also, num-
ber of stools per week correlated with fasting breath hydrogen 
levels among patients with IBS. Our finding of correlation of 
stool frequency and fasting breath hydrogen level, albeit weakly, 
suggests fasting breath hydrogen levels might correlate with 
diarrhea.
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